Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**GPN-loop GTPase 2 (GPN2)** is a member of the evolutionarily conserved GPN-loop GTPase enzyme family, defined by a unique Gly-Pro-Asn (GPN) motif in the G-domain, typically involved in GTP binding and hydrolysis. In humans, there are three paralogs: GPN1, GPN2, and GPN3. GPN2 functions as an essential assembly chaperone for the biogenesis of the 12-subunit RNA polymerase II (Pol II) complex, preventing misassembly or aggregation by binding and releasing hydrophobic peptide regions in subunits through a GTP-dependent mechanism involving large conformational changes. It forms part of a broader family (SIMIBI class) of GTPases that typically assemble as homo- or heterodimers and operate via a "lock-switch-rock" mechanism to facilitate complex allosteric assembly processes. Loss-of-function of GPN2 in yeast is lethal, underlining its essential cellular role. There are currently no known direct pharmacologic agents, disease associations, or clinical biomarkers based on available data[1][2]. **Notes:** - GPN2 is NOT considered a direct therapeutic target or receptor but rather an essential enzyme for assembly of critical cellular complexes[1][2]. - There are no current drugs, biomarkers, or safety concerns associated with GPN2 based on present knowledge. - No evidence of incorrect assignment, spelling, or concept.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPN-loop GTPase 2 (GPN2).